Advertisement
REPL Novinky na Forexe
Replimune Promotes Sushil Patel To Succeed Philip Astley-Sparke As CEO
Biotechnology company Replimune Group, Inc. (REPL) announced Tuesday changes to its executive leadership team designed to support the Company's preparations for the commercial launch of RP1, pending regulatory submission and approval in anti-PD1 failed melanoma.
RTTNews
|
Pred 521 dňami
Replimune Group Appoints Emily Hill As CFO
Biotechnology company Replimune Group, Inc. (REPL) announced Tuesday the appointment of Emily Hill as Chief Financial Officer. Hill was most recently CFO of the commercial stage biotech company PTC Therapeutics.
RTTNews
|
Pred 710 dňami
